Pfizer's coronavirus vaccine could face some headwinds in the near future. The company will enter a period of patent cliffs ...

Pfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of ...

The end date is what is known, in industry jargon, as a patent cliff. Essentially, when its patent ends, the revenue from a medication "falls off a cliff" as generic alternatives are introduced.

Pfizer (NYSE: PFE) has been around for over 175 years, but it became a true household name during the COVID-19 pandemic as one of the main vaccine suppliers. That led to its stock price and revenue ...

If you own or are considering buying pharma laggards Pfizer (NYSE: PFE), Bristol Myers Squibb (NYSE: BMY), and Merck (NYSE: ...

If you are looking to own a stock for the long term, these out-of-favor drugmakers have proven they have what it takes to ...

The Vigo County History Center public exhibits display a fantastic representation of various aspects of local history. If you still haven’t seen it in person, I highly recommend you do. But for all ...

A list of high-quality dividend growth stocks is identified based on proximity to 52-week lows. Pfizer, Bristol-Myers Squibb, ResMed, and NextEra Energy appear attractively valued based on Future and ...

3SBio, a China partner of U.S. drug giant Pfizer, has reached agreements to raise approximately $400 million in a share ...

Pfizer possesses several qualities that make it attractive when market volatility is high. The stock has a low forward ...

A list of high-quality dividend-growth stocks trading near 52-week lows is evaluated based on historical and future fair values. Pfizer's financial health is concerning, with unsustainable dividend ...